Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethambutol in tuberculosis.

L M Kahana1

  • 1McMaster University, Hamilton, Ontario, Canada.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Ethambutol, used for tuberculosis treatment, can cause serious vision loss even at standard doses. Due to its unpredictable ocular toxicity and minimal contribution to modern regimens, less toxic alternatives are recommended.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Needle Biopsy as an Aid to the Precise Diagnosis of Intrathoracic Disease.

Canadian Medical Association journal·2010
Same author

Living with lung cancer: the other side of the desk.

Chest·2000
Same author

TB among aboriginal Canadians.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2000
Same author

Pneumonitis due to Mycobacterium avium complex in hot tub water: infection or hypersensitivity?

Chest·1997
Same author

Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure.

Chest·1997
Same author

Diffuse smooth muscle proliferation of the lungs with severe pulmonary hypertension.

Human pathology·1996
Same journal

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Area of Science:

  • Pharmacology
  • Ophthalmology
  • Infectious Disease

Background:

  • Ethambutol was widely adopted for tuberculosis treatment due to better patient tolerance and ease of administration compared to PAS.
  • Early concerns about ethambutol's ocular toxicity were primarily associated with higher dosages.

Purpose of the Study:

  • To review the ocular toxicity associated with ethambutol, even at conventional doses.
  • To evaluate the role of ethambutol in modern tuberculosis therapy.

Main Methods:

  • Review of existing literature and case reports on ethambutol-induced optic neuritis.
  • Analysis of ethambutol's contribution to current short-course tuberculosis treatment regimens.

Main Results:

  • Despite early assumptions, significant visual impairment, including permanent blindness and slow recovery, has been reported with conventional ethambutol dosages.

Related Experiment Videos

  • The exact mechanism of ethambutol-induced optic neuritis remains unclear, and individual patient susceptibility is unpredictable.
  • Ethambutol's role in contemporary short-course tuberculosis regimens is minimal.

    • Conclusions:

    • Ethambutol poses a risk of serious, unpredictable ocular toxicity, even at recommended doses.
    • Given its marginal benefit in modern treatment protocols, ethambutol should be substituted with safer alternatives for tuberculosis management.